文献速递胸部骨肌技术与安全DR

美国应用深度学习基于胸部X线片进行机会性骨质疏松筛查的成本效益

Cost-Effectiveness of Opportunistic Osteoporosis Screening Using Chest Radiographs With Deep Learning in the United States.
PubMed 文献 · J Am Coll Radiol · 2025-08-06

本研究采用经济模型评估美国50岁及以上女性中,利用深度学习对因其他临床原因拍摄的胸部X线片进行机会性骨质疏松筛查并随后治疗,与不筛查不治疗相比的成本效益。机会性筛查策略获得更多QALY并减少骨折,但增加治疗成本,每获得一个QALY的成本为72,085美元,低于美国100,000美元/QALY的成本效益阈值。优化随访、治疗启动和用药依从性可进一步改善成本效益。

要点

  • 深度学习辅助胸部X线片机会性骨质疏松筛查在美国50岁及以上女性中每QALY成本72,085美元。
  • 该成本低于美国100,000美元/QALY的成本效益阈值。
  • 机会性筛查策略获得更多QALY并减少骨折,但增加治疗成本。

核心结论

  • 对于美国50岁及以上女性,利用深度学习对胸部X线片进行机会性骨质疏松筛查并随后治疗,与不筛查不治疗相比,每获得一个QALY的成本为72,085美元,低于美国100,000美元/QALY的成本效益阈值,该策略改善健康结局并减少骨折。

研究设计与样本

  • 经济模型研究,结合决策树和微观模拟马尔可夫模型,评估通过深度学习胸部X线片筛查后治疗与不筛查不治疗相比每获得一个质量调整生命年(QALY)的成本(2024年美元),患者路径基于人工智能增强X线片的敏感度和特异度,并纳入真实世界药物持久性、筛查检出后双能X线吸收测定法检查概率及治疗启动率的现实假设。

诊断标准与关键数值

  • 骨质疏松女性分为高风险(接受阿仑膦酸钠单药治疗5年)和极高风险(接受18个月阿巴洛肽合成代谢治疗后续5年阿仑膦酸钠)。
  • 机会性筛查策略每获得一个QALY的成本为72,085美元(50岁及以上女性),低于美国100,000美元/QALY的成本效益阈值。

局限性

  • 研究结论基于经济模型和现实假设,参数不确定性通过敏感性分析处理。
  • 进一步改善成本效益可通过优化随访、治疗启动和用药依从性实现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Deep learning models applied to chest radiographs obtained for other clinical reasons have shown promise in opportunistic osteoporosis screening, particularly among middle-aged to older individuals. This study evaluates the cost-effectiveness of this approach in US women aged 50 years and over.

METHODS: An economic model, incorporating both a decision tree and a microsimulation Markov model, estimated the cost per quality-adjusted life-year (QALY) gained (in 2024 US dollars) for screening via chest radiographs with deep learning, followed by treatment, versus no screening and treatment. The patient pathways were based on the sensitivity and specificity of artificial intelligence-enhanced radiographs. Real-world medication persistence, realistic assumptions for probabilities of dual-energy x-ray absorptiometry examination postscreening detection and for treatment initiation rates were incorporated. Women with osteoporosis were stratified into high risk (receiving alendronate monotherapy for 5 years) and very high risk (receiving an 18-month anabolic treatment with abaloparatide followed by 5 years of alendronate). Parameter uncertainty was analyzed through sensitivity analyses.

RESULTS: The opportunistic screening strategy improved health outcomes, yielding more QALYs and fewer fractures while increasing treatment costs. The cost per QALY gained of opportunistic screening was estimated at $72,085 per QALY gained among women 50+, remaining below the US cost-effectiveness threshold of $100,000 per QALY. Further improvements in cost-effectiveness could be achieved by optimizing follow-up, treatment initiation, and medication adherence.

DISCUSSION: This study underscores the cost-effectiveness and public health value of opportunistic, artificial intelligence-driven screening osteoporosis screening using existing chest radiographs, demonstrating its potential to improve early detection and address unmet diagnostic needs in osteoporosis care.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Hiligsmann M, Silverman SL, Reginster JY, et al. Cost-Effectiveness of Opportunistic Osteoporosis Screening Using Chest Radiographs With Deep Learning in the United States. J Am Coll Radiol. 2025. PMID: 40780311. doi:10.1016/j.jacr.2025.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。